Cambridge, MA, United States of America

Evangelos Kiskinis

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Boston, MA (US) (2016 - 2019)
  • Cambridge, MA (US) (2017 - 2020)

Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Evangelos Kiskinis: Pioneering Diagnostic Methods for Neural Disorders

Introduction

Evangelos Kiskinis is a distinguished inventor based in Cambridge, MA, with an impressive portfolio of six patents. His work primarily focuses on innovative diagnostic methods and treatments for neurodegenerative diseases, contributing significantly to advancements in neuroscience.

Latest Patents

One of Evangelos Kiskinis's latest patents is centered around diagnostic methods for neural disorders. This invention relates to optical methods for diagnosing neuronal conditions by transforming a cell from a patient into a neuron and optically evaluating its action potentials in vitro. The process involves the use of an optical reporter that exhibits a distinct optical signature when the neuron undergoes neural stimulation. By employing genome-editing techniques, a control cell can be developed which is isogenic except for a specific mutation, allowing for the comparison of optical signatures between the patient-derived cell and the control. This innovative approach highlights the potential neurodegenerative effects of mutations within a patient's genetic context, with correlation to diagnoses of neurodegenerative diseases.

Additionally, his patent regarding methods to treat neurodegenerative diseases outlines novel compositions and strategies aimed at providing therapeutic options for affected individuals. This work underscores his commitment to not only understanding neurological conditions but also translating that knowledge into viable treatment solutions.

Career Highlights

Evangelos Kiskinis has worked with notable organizations such as Q-State Biosciences, Inc. and The General Hospital Corporation. His tenure at these institutions has solidified his reputation as a thought leader in the realm of neuroscience and biotechnology. His contributions continue to shape the landscape of medical research and diagnostics.

Collaborations

Throughout his career, Kiskinis has collaborated with esteemed colleagues, including Kevin C. Eggan and Adam Ezra Cohen. These partnerships have fostered a collaborative environment that promotes innovative research and development, driving progress in understanding and addressing neural disorders.

Conclusion

Evangelos Kiskinis stands out as a pioneering inventor whose work in the field of neuroscience provides hope for better diagnosis and treatments of neurodegenerative diseases. With his extensive patent portfolio and impactful collaborations, he continues to make significant strides toward understanding the complexities of neuronal conditions, ultimately benefiting patients and advancing the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…